Commutee

Bayer faces second trial over alleged Roundup cancer risk

February 24, 2019 by  
Filed under News

Bayer AG is set to face a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company’s share price was rocked by a $289 million verdict in California state court.


Source: Reuters Business News

Comments are closed.